EBV-Tscm Cytotoxic T Cells（University Hospital Basel）

N/A

Report date: 2024/03/28 15:55:24

Base Information

Drug NameEBV-Tscm Cytotoxic T Cells（University Hospital Basel）
Drug Alias NameEBV-CTLs（University Hospital Basel）Epstein-Barr Virus (EBV) -Specific T Memory Stem Cell（University Hospital Basel）Epstein-Barr Virus (EBV) -Specific Tscm（University Hospital Basel）Donor-derived ex-vivo expanded EBV Tscm CTL（University Hospital Basel）
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Virus-specific T Cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Memory T cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Cytotoxic T-lymphocytes therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLymphomaEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Basel
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital Basel
Inactive CompaniesN/A
Active IndicationsLymphomaEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A